/

Investors / United States / BEVC

BEVC

Venture capital · Berkeley, CA, United States · North America

bevc.com

BEVC is an early-stage venture capital firm founded by scientists and entrepreneurs that invests in companies translating academic research into commercial technology. It is based in Berkeley and works closely with the Berkeley and UCSF research ecosystems, providing technical, strategic and operational support to founders.

Invests inHealthcare & BiotechClimate & Energy

In its own wordshealthenergymaterialsdeep techartificial intelligencelife sciences

Your fit with BEVC

Three questions about your startup

See how your round matches what it backs, point by point.

Or find every investor that fits
10portfolio companies
3funding rounds on recordnamed lead in 1 of 3 that name one
3rounds, last 12 months
Pre-seedmost frequent entryn=2 known entries

BEVC lists 12 companies on its own site, 10 of them checked. It is named in 3 funding rounds, 1 of them as lead. Its most frequent entry is Pre-seed, 50% of the 2 companies where the round it came in at is known. Its largest themes are Healthcare & Biotech (70%), Climate & Energy (20%) and Industrial & Manufacturing (10%). 100% of its 9 companies with a known country are based in United States. It shares the most portfolio companies with KdT Ventures, 10VC and AP Ventures.

Counts come from funding rounds that name BEVC, complete from mid-2025: earlier rounds appear only when they were reported later. Reports often leave out co-leads, so a firm may have led more rounds than shown. Round amounts and full round histories are on Fundup AI.

Round figures show recent activity, not BEVC's whole history. Rounds on record name 3 companies; its own site lists 12. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.

Entry stage

share of companies by the stage it came in at · n=2

Counted only where the round is where it came in: a pre-seed or seed round, or a later round after the company raised without it.

Show as a table
Share of companies by the stage the firm came in at
Value
Pre-seed50%
Seed0%
Series A0%
Series B0%
Growth50%

Activity by year

rounds it joined, last 10 years
Show as a table
Funding rounds per year
TotalRounds it led
'1700
'1800
'1900
'2000
'2100
'2200
'2300
'2400
'2510
'2621

Investor profile

percentile among all firms
Portfolio size: 10 companiesRecent activity: 3 rounds in 12 monthsEarly stage: 50% of 2 known entries at pre-seed or seedEvidence: 10% of companies confirmed by a roundSector focus: 70% of companies in its largest themeReach: 1 country, from 9 companies with a known countryPortfolio size21st pctRecent activity71st pctEarly stage13th pctEvidence75th pctSector focus84th pctReach10th pct
This firmMedian of all firms
Show as a table
BEVC compared with all firms
MeasurePercentile of all firmsValue
Portfolio size21st10 companies
Recent activity71st3 rounds in 12 months
Early stage13th50% of 2 known entries at pre-seed or seed
Evidence75th10% of companies confirmed by a round
Sector focus84th70% of companies in its largest theme
Reach10th1 country, from 9 companies with a known country

Investment themes

share of its 10 companies with a theme; a company can have two

This firmAll checked companies

Show as a table
Investment themes
This firmAll checked companies
Healthcare & Biotech70%17%
Climate & Energy20%7%
Industrial & Manufacturing10%3%
AI & Machine Learning10%13%
Advanced Materials & Chemicals10%2%

Invests in the same rounds as

named on the same funding round, and both list the company on their own site
Show as a table
Firms in the same rounds
Share
Abingworth1
Pivotal Life Sciences1
SR One1

All co-investors

Its portfolio companies

where they are based, and what their own sites show

Headquarters

Site status

  • Site answers990%
  • No longer answers00%
  • Points to another company110%
  • Parked or sold domain00%

A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.

Compare BEVC head to head

portfolio size, rounds, entry stages, themes and the companies both back

Three or more firms at once: portfolio overlap.

Recent portfolio activity

when companies last raised with BEVC
DateCompanyStage
18 Nov 2026Ansaansabio.comSeries C+
26 Aug 2026Teragen Energyteragenenergy.comPre-Seed Led
17 Dec 2025Addition Therapeuticsadditiontx.comSeries A

Round details for BEVC

Amounts, full round histories and every co-investor in BEVC's rounds are on Fundup AI. VCinfo covers investors and their portfolios.

See rounds on Fundup AI →

Portfolio

10 companies checked against their own sites
CompanyWhat it doesThemesFirst round with itEvidence
Addition Therapeuticsadditiontx.com · United StatesAddition Therapeutics is advancing a pipeline of therapeutics to deliver functional cures for patients with severe lifelong diseases
Healthcare & Biotech
Dec 2025Series APage + round
AimatXaimatx.ai · United States
Industrial & ManufacturingAI & Machine Learning
Portfolio page
Ansaansabio.com · United StatesAnsa Biotechnologies synthesizes custom DNA sequences for its customers.
Healthcare & Biotech
Nov 2026Series C+Funding round
Dextera Biosciencesdexterabio.comDextera Biosciences is pioneering a new class of therapeutics—dexabodies—built entirely from D-amino acids to overcome the key limitations of existing drug modalities
Healthcare & Biotech
Portfolio page
Insamoinsamo.com · United StatesInsamo discovers drugs for challenging diseases using a platform that designs, synthesizes, and tests cyclic-peptides
Healthcare & Biotech
Portfolio page
Khemia Metalskhemiametals.com · United StatesKhemia Metals makes lighter, cheaper, and more sustainable batteries using earth-abundant alloys.
Climate & EnergyAdvanced Materials & Chemicals
Portfolio page
Montara Therapeuticsmontaratx.com · United StatesMontara Therapeutics is developing safer, more efficacious therapies to improve the lives of patients with neurological diseases.
Healthcare & Biotech
Portfolio page
PinkDxpinkdx.com · United StatesThe company is developing a test to detect endometrial cancer from a simple, non-invasive vaginal swab.
Healthcare & Biotech
Portfolio page
Radar Therapeuticsradartx.bio · United StatesRadar Therapeutics is pioneering a new treatment modality: precision-expressed mRNA-based therapeutics.
Healthcare & Biotech
Portfolio page
Teragen Energyteragenenergy.com · United StatesTeragen Energy builds advanced fuel cell systems to bring fast, reliable, affordable, clean power where it's needed most.
Climate & Energy
Aug 2026Pre-SeedFunding round

About this data

site last read 19 Nov 2026
The homepage of BEVC, as last read
bevc.com as VCinfo last read it
Site
bevc.com
Last read
19 Nov 2026
Watching since
19 Nov 2026
Rounds since
17 Dec 2025
Companies checked
10

Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.

How we grade the data

Free account · no card

Get BEVC's profile as data

Pull BEVC's portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.

Work email, sign-in link by email. Already have an account? Log in
  • Ask AI5 plain-English investor searches a day
  • Full listsEvery portfolio row and two-firm overlap
  • API and MCP100 REST or MCP calls a month, one key
  • AlertsFollow 5 investors for portfolio and fund changes
VCinfo API
$ curl -H "X-API-Key: YOUR_KEY" \
  https://api.vcinfo.io/v1/firms/bevc.com

# also
GET /v1/firms/bevc.com/portfolio
GET /v1/firms/bevc.com/coinvestors
GET /v1/firms/bevc.com/news
The same data as an MCP server for Claude, Cursor and other AI tools. Set up MCP · Docs · Pricing